Spis treści:
Spis załącznikĂłw:
Audited_consolidated_and_unconsolidated_annual_report_for_the_year_2016.pdf (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załącznikĂłw:
Audited_consolidated_and_unconsolidated_annual_report_for_the_year_2016.pdf (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 13 | / | 2017 | ||||||||
| Date of issue: | 2017-04-06 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Audited consolidated and unconsolidated annual report for the year 2016 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| See attached document. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Audited consolidated and unconsolidated annual report for the year 2016.pdfAudited consolidated and unconsolidated annual report for the year 2016.pdf | Audited consolidated and unconsolidated annual report for the year 2016 | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-04-06 | Jože Colarič | President of the Management Board | |||
Źródło:Komunikaty spółek (ESPI)
